Search Results - "De Lima, Valéria M F"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
  2. 2

    Immunotherapy against murine experimental visceral leishmaniasis with the FML-vaccine by Santos, Wania Renata, Aguiar, Ivan Augusto, de Souza, Edilma Paraguai, de Lima, Valéria M.F, Palatnik, Marcos, Palatnik-de-Sousa, Clarisa Beatriz

    Published in Vaccine (01-12-2003)
    “…The fucose mannose ligand ( Leishmania donovani FML)-saponin vaccine has earlier shown its immunoprophylactic potential against visceral leishmaniasis in the…”
    Get full text
    Journal Article
  3. 3

    Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis by Santos, Wania Renata, de Lima, Valeria M.F, de Souza, Edilma Paraguai, Bernardo, Robson Ronney, Palatnik, Marcos, de Sousa, Clarisa Beatriz Palatnik

    Published in Vaccine (22-11-2002)
    “…The FML antigen of Leishmania donovani, in combination with either Riedel de Haën (R), QuilA, QS21 saponins, IL12 or BCG, was used in vaccination of an outbred…”
    Get full text
    Journal Article
  4. 4

    Polymerase chain reaction evaluation for canine visceral leishmaniasis diagnosis in dog blood samples by Nunes, Cáris M, Dias, Ana Karina K, Gottardi, Fernanda Patricia, De Paula, Henrique B, De Azevedo, Márcia A A, De Lima, Valéria M F, Garcia, José Fernando

    “…Canine and human visceral leishmaniasis is endemic in several States of Brazil, and it is associated with infected dogs and the presence of the vector. Aiming…”
    Get full text
    Journal Article
  5. 5

    IL-6 and TNF-α production during active canine visceral leishmaniasis by de Lima, Valeria M.F., Peiro, Juliana Regina, de Oliveira Vasconcelos, Rosemeri

    Published in Veterinary Immunology and Immunopathology (15-01-2007)
    “…We investigated the production of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) during canine visceral leishmaniasis (VL) to gain a better…”
    Get full text
    Journal Article